Esther Martinborough
Direktor/Vorstandsmitglied bei CODEXIS, INC.
Vermögen: 153 522 $ am 30.04.2024
Profil
Esther Martinborough is an Independent Director at Codexis, Inc. since 2021.
She is also the Chief Scientific Officer at Escient Pharmaceuticals, Inc. since 2018.
Prior to her current positions, she worked as the Executive Director-Research at Receptos LLC from 2008 to 2018.
Dr. Martinborough holds a doctorate degree from the Swiss Federal Institute of Technology and a graduate degree from the University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CODEXIS, INC.
0,08% | 18.04.2024 | 57 933 ( 0,08% ) | 153 522 $ | 30.04.2024 |
Aktive Positionen von Esther Martinborough
| Unternehmen | Position | Beginn |
|---|---|---|
| CODEXIS, INC. | Direktor/Vorstandsmitglied | 02.02.2021 |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2023 |
Ehemalige bekannte Positionen von Esther Martinborough
| Unternehmen | Position | Ende |
|---|---|---|
| RECEPTOS INC | Direktor/Vorstandsmitglied | 01.01.2015 |
Ausbildung von Esther Martinborough
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of California | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CODEXIS, INC. | Process Industries |
| Private Unternehmen | 2 |
|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
